MTE #15 - Management of Benign Liver Lesions: What to Do If It’s Not a Cancer
Review common benign liver lesions and their management.
Review common benign liver lesions and their management.
The PharmD is an integral part the multidisciplinary team. In this session you will gain insight from a PharmD on their unique role as a member of the Hepatology and Transplant team in improving patient outcomes.
Andrea Gossard is a Certified Nurse Practitioner, an Associate Professor of Medicine and a Director of NP PA practice at Mayo Clinic in Rochester, Minnesota. Her clinical and research interests are focused on the diagnosis and management of cholestatic and autoimme liver diseases including Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis. She is an Associate Fellow of the American Association for the Study of Liver Disease (AASLD) and Chair of the Hepatology Associates Special Interest Group. In addition, she is a member of the American Gastroenterology Association (AGA) and the American College of Gastroenterology (ACG).
Andrea was one of the founding members of Gastroenterology and Hepatology for Advanced Practice Providers (GHAPP), an association led by Advanced Practice Providers (APPs) and committed to education and professional development of APPs. She remains on the Board of Trustees.
The American Association for the Study of Liver Diseases (AASLD) acknowledges the important open letter by Rainbows in Gastro...
Steatotic liver disease (SLD) is the new overarching term with metabolic dysfunction-associated steatotic liver disease (MASLD)...
No more NAFLD! Steatotic Liver Disease is the overarching term; NAFLD is now MASLD.